IBDEI09U ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,4185,1,4,0)
 ;;=4^V79.8
 ;;^UTILITY(U,$J,358.3,4185,2)
 ;;=^295681
 ;;^UTILITY(U,$J,358.3,4186,0)
 ;;=V80.01^^17^196^60
 ;;^UTILITY(U,$J,358.3,4186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4186,1,3,0)
 ;;=3^SCREEN-TRAUMTC BRAIN INJ
 ;;^UTILITY(U,$J,358.3,4186,1,4,0)
 ;;=4^V80.01
 ;;^UTILITY(U,$J,358.3,4186,2)
 ;;=^338517
 ;;^UTILITY(U,$J,358.3,4187,0)
 ;;=V80.09^^17^196^45
 ;;^UTILITY(U,$J,358.3,4187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4187,1,3,0)
 ;;=3^SCREEN-NEURO CONDITION
 ;;^UTILITY(U,$J,358.3,4187,1,4,0)
 ;;=4^V80.09
 ;;^UTILITY(U,$J,358.3,4187,2)
 ;;=^338518
 ;;^UTILITY(U,$J,358.3,4188,0)
 ;;=V80.1^^17^196^26
 ;;^UTILITY(U,$J,358.3,4188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4188,1,3,0)
 ;;=3^SCREEN-GLAUCOMA
 ;;^UTILITY(U,$J,358.3,4188,1,4,0)
 ;;=4^V80.1
 ;;^UTILITY(U,$J,358.3,4188,2)
 ;;=^295684
 ;;^UTILITY(U,$J,358.3,4189,0)
 ;;=V80.2^^17^196^21
 ;;^UTILITY(U,$J,358.3,4189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4189,1,3,0)
 ;;=3^SCREEN-EYE COND NEC
 ;;^UTILITY(U,$J,358.3,4189,1,4,0)
 ;;=4^V80.2
 ;;^UTILITY(U,$J,358.3,4189,2)
 ;;=^295685
 ;;^UTILITY(U,$J,358.3,4190,0)
 ;;=V80.3^^17^196^20
 ;;^UTILITY(U,$J,358.3,4190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4190,1,3,0)
 ;;=3^SCREEN-EAR DIS
 ;;^UTILITY(U,$J,358.3,4190,1,4,0)
 ;;=4^V80.3
 ;;^UTILITY(U,$J,358.3,4190,2)
 ;;=^295686
 ;;^UTILITY(U,$J,358.3,4191,0)
 ;;=V81.0^^17^196^35
 ;;^UTILITY(U,$J,358.3,4191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4191,1,3,0)
 ;;=3^SCREEN-ISCHEMIC HEART DIS
 ;;^UTILITY(U,$J,358.3,4191,1,4,0)
 ;;=4^V81.0
 ;;^UTILITY(U,$J,358.3,4191,2)
 ;;=^295687
 ;;^UTILITY(U,$J,358.3,4192,0)
 ;;=V81.1^^17^196^32
 ;;^UTILITY(U,$J,358.3,4192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4192,1,3,0)
 ;;=3^SCREEN-HYPERTENSION
 ;;^UTILITY(U,$J,358.3,4192,1,4,0)
 ;;=4^V81.1
 ;;^UTILITY(U,$J,358.3,4192,2)
 ;;=^295688
 ;;^UTILITY(U,$J,358.3,4193,0)
 ;;=V81.2^^17^196^9
 ;;^UTILITY(U,$J,358.3,4193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4193,1,3,0)
 ;;=3^SCREEN-CARDIOVASC NEC
 ;;^UTILITY(U,$J,358.3,4193,1,4,0)
 ;;=4^V81.2
 ;;^UTILITY(U,$J,358.3,4193,2)
 ;;=^295689
 ;;^UTILITY(U,$J,358.3,4194,0)
 ;;=V81.3^^17^196^8
 ;;^UTILITY(U,$J,358.3,4194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4194,1,3,0)
 ;;=3^SCREEN-BRONCH/EMPHYSEMA
 ;;^UTILITY(U,$J,358.3,4194,1,4,0)
 ;;=4^V81.3
 ;;^UTILITY(U,$J,358.3,4194,2)
 ;;=^295690
 ;;^UTILITY(U,$J,358.3,4195,0)
 ;;=V81.4^^17^196^52
 ;;^UTILITY(U,$J,358.3,4195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4195,1,3,0)
 ;;=3^SCREEN-RESPIR COND NEC
 ;;^UTILITY(U,$J,358.3,4195,1,4,0)
 ;;=4^V81.4
 ;;^UTILITY(U,$J,358.3,4195,2)
 ;;=^295691
 ;;^UTILITY(U,$J,358.3,4196,0)
 ;;=V81.5^^17^196^44
 ;;^UTILITY(U,$J,358.3,4196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4196,1,3,0)
 ;;=3^SCREEN-NEPHROPATHY
 ;;^UTILITY(U,$J,358.3,4196,1,4,0)
 ;;=4^V81.5
 ;;^UTILITY(U,$J,358.3,4196,2)
 ;;=^295692
 ;;^UTILITY(U,$J,358.3,4197,0)
 ;;=V81.6^^17^196^28
 ;;^UTILITY(U,$J,358.3,4197,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4197,1,3,0)
 ;;=3^SCREEN-GU COND NEC
 ;;^UTILITY(U,$J,358.3,4197,1,4,0)
 ;;=4^V81.6
 ;;^UTILITY(U,$J,358.3,4197,2)
 ;;=^295693
 ;;^UTILITY(U,$J,358.3,4198,0)
 ;;=V82.0^^17^196^58
 ;;^UTILITY(U,$J,358.3,4198,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4198,1,3,0)
 ;;=3^SCREEN-SKIN COND
 ;;^UTILITY(U,$J,358.3,4198,1,4,0)
 ;;=4^V82.0
 ;;^UTILITY(U,$J,358.3,4198,2)
 ;;=^295694
 ;;^UTILITY(U,$J,358.3,4199,0)
 ;;=V82.1^^17^196^54
 ;;^UTILITY(U,$J,358.3,4199,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,4199,1,3,0)
 ;;=3^SCREEN-RHEUMATOID ARTHR
 ;;^UTILITY(U,$J,358.3,4199,1,4,0)
 ;;=4^V82.1
 ;;
 ;;$END ROU IBDEI09U
